What You Should Know:
Today, Nucleus RadioPharma the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals has announced an oversubscribed $56 million Series A funding round led by Eclipse and GE HealthCare with participation from Echo Global, Fox Chase Cancer Center, Granger Management, Mayo Clinic, Mercy Health, and University of Missouri.With this round of funding,
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Gero Raises $6M for Physics-Powered GenAI Biotech
What You Should Know:
Gero, a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round.This funding round positions Gero to continue internal drug development programs, grow its scientific team to boost platform technology development, and expand its US presence. The round was led by Melnichek Investments, a Cyprus-based VC firm that seeks to improve the quality of human lives by funding and supporting promising, potentially high-impact,
Read More
Chan Zuckerberg Initiative Launches Biohub in New York for Early Disease Prevention, Detection, and Treatment
What You Should Know:
- The Chan Zuckerberg Initiative (CZI) announced the launch of a new biomedical research hub in New York City that will catalyze collaboration between leading scientific and technology institutions in the area, with the goal of solving grand scientific challenges on 10- to 15-year time horizons.
- The CZ Biohub NY is the fourth research institute in the Chan Zuckerberg Biohub Network, a groundbreaking collaborative model for scientific research. The
Read More
Ozempic: From Diabetes Management to Potential Weight Loss Miracle
You've probably heard about Ozempic, especially if you're one of the millions who regularly scroll through TikTok or browse other social media platforms. It's the drug that influencers are lauding as a revolutionary aid for weight loss, making it a hot topic of conversation.
While Ozempic was initially developed to manage Type 2 diabetes, its emerging potential for weight loss is captivating medical professionals and the public alike.
How Ozempic Works: The Basics
Ozempic is a
Read More
H1 Launches Gen AI Tool to Accelerate Clinical Trials
What You Should Know:
H1, the leading source of truth for global Healthcare Professional, clinical, scientific, and research information, today announced the launch of GenosAI, a new generative AI tool seamlessly embedded into its clinical trial intelligence platform, Trial Landscape, to analyze and respond to all types of complex inquiries. Trial Landscape allows sponsors to identify new sites, centers of excellence, and investigators with diverse patients; evaluate site and PI patient
Read More
Medable & Pluto Health Partner to Increase Patient Access to Clinical Trials
What You Should Know:
- Medable Inc., a technology provider for modern clinical trials forms an enterprise partnership with Pluto Health, a smart care coordination services company.
- The partnership brings together two best-in-class technology solutions in healthcare to streamline clinical trial execution, improve data quality in trials, and enhance the patient experience from study start and long after the trial is over.
Optimize Patient Experience and Improve Access
Read More
Mayo Clinic, Phenomix Awarded First Patent for Obesity Phenotyping
What You Should Know:
- Phenomix Sciences, a precision medicine biotechnology company that brings data-driven precision medicine to obesity treatment, announced it has been awarded the first patent related to its obesity phenotyping technology.
- The patent (No. 11,740,247, titled “Methods and Materials for Assessing and Treating Obesity”) covers methods for treating obesity by identifying phenotypes through obesity analyte signatures and administering interventions, such
Read More
Komodo Health Launches MapLab For Enterprise Healthcare Insights
What You Should Know:
Komodo Health today introduced MapLab™, the first all-in-one offering for healthcare and Life Sciences companies to generate insights into disease trends, treatment pathways, patient populations, and a host of other complex research questions.The technology ushers in a new, fully integrated insights workflow solution for the industry to more easily and rapidly unearth rich insights that will help reduce disease burden at scale. MapLab includes robust data science
Read More
Atropos Health Partners, Janssen Partner to Accelerate Clinical Trials with RWD
What You Should Know:
Atropos Health, a pioneer in evidence-based healthcare known for its Green Button Clinical Informatics Consult Service, today announced an agreement with Janssen Research & Development, LLC (Janssen), a Johnson & Johnson company, to help accelerate clinical development with real-world data analysis.Building upon an existing collaboration, under the new agreement, Atropos and Janssen data scientists will utilize Atropos’s software platform to interrogate
Read More
Mission Bio Announces and Launches Single-Cell Measurable Residual Disease (MRD) Assay
What You Should Know:
Mission Bio, a leader in single-cell multi-omic solutions for precision medicine, announced the commercial launch of the Tapestri® Single-cell MRD (scMRD) AML Multiomics Assay.The company designed the scMRD AML Multiomics Assay to bring unprecedented resolution to disease relapse and recurrence in acute myeloid leukemia (AML), demonstrating the potential of single-cell DNA and protein multiomics to identify therapeutic targets in recurrent AML.
Unearthing
Read More
